Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024
Compare Balance Sheet Results of Shelter Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
11.56
33.00
-21.44
-64.97%
Share Warrants & Outstandings
Total Reserve
31.16
6.46
24.70
382.35%
Shareholder's Funds
42.72
39.46
3.26
8.26%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.93
0.38
0.55
144.74%
Secured Loans
0.00
0.15
-0.15
-100.00%
Unsecured Loans
0.93
0.23
0.70
304.35%
Deferred Tax Assets / Liabilities
-0.03
0.33
-0.36
-109.09%
Other Long Term Liabilities
0.05
0.00
0.05
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.13
-0.13
-100.00%
Total Non-Current Liabilities
0.95
0.84
0.11
13.10%
Current Liabilities
Trade Payables
1.25
17.76
-16.51
-92.96%
Other Current Liabilities
3.27
3.57
-0.30
-8.40%
Short Term Borrowings
0.11
10.21
-10.10
-98.92%
Short Term Provisions
0.00
0.08
-0.08
-100.00%
Total Current Liabilities
4.63
31.62
-26.99
-85.36%
Total Liabilities
48.30
71.91
-23.61
-32.83%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
8.36
10.98
-2.62
-23.86%
Less: Accumulated Depreciation
2.39
1.37
1.02
74.45%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.96
9.61
-3.65
-37.98%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.68
0.00
0.68
0.00%
Long Term Loans & Advances
8.39
0.17
8.22
4,835.29%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
15.03
12.41
2.62
21.11%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
12.90
23.24
-10.34
-44.49%
Sundry Debtors
9.47
34.95
-25.48
-72.90%
Cash and Bank
3.42
0.06
3.36
5,600.00%
Other Current Assets
1.77
0.00
1.77
0.00%
Short Term Loans and Advances
5.72
1.25
4.47
357.60%
Total Current Assets
33.28
59.50
-26.22
-44.07%
Net Current Assets (Including Current Investments)
28.65
27.88
0.77
2.76%
Total Current Assets Excluding Current Investments
33.28
59.50
-26.22
-44.07%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
48.30
71.91
-23.61
-32.83%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
1.04
10.59
-9.55
-90.18%
Book Value per share (adjusted)
36.14
11.42
24.72
216.46%
Annual - Borrowings
Borrowings 1.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.05 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Annual - Investments
Investments 0.68 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 33.28 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024






